Internal Medicine, Hematology & Oncology · Port St Lucie, FL
NPI
1891089587
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1871 SE Tiffany Ave Ste 100
Port St Lucie, FL, 34952
Phone (772) 335-5666
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.8M
260,606 services
Medicare patients, 2024
1,176
Average age 76
Drug cost, 2024
$7.2M
2,752 prescriptions
Company payments, 2025
$15K
From 39 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Phu N Tran was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 57,120 times for 58 patients. In total Phu N Tran billed 260,606 services in 164 codes, and Medicare paid $3.8M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 57,120 | 58 | $0.27 | $15K |
| Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | Office | 34,560 | 23 | $0.39 | $13K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 18,400 | 25 | $44.67 | $822K |
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 17,460 | 14 | $0.22 | $3,803 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 7,875 | 37 | $0.10 | $797 |
| J0897 Injection, denosumab, 1 mg | Office | 6,660 | 43 | $20.41 | $136K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 5,048 | 58 | $0.09 | $448 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 4,430 | 30 | $5.77 | $26K |
| 85025 Blood Count | Office | 2,302 | 747 | $7.58 | $17K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 2,219 | 66 | $0.23 | $508 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,660 | 37 | $0.73 | $1,204 |
| 36415 Venipuncture Blood Collection | Office | 1,614 | 625 | $8.65 | $14K |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 1,588 | 14 | $3.58 | $5,690 |
| 99214 Office E&M - Established | Office | 1,039 | 266 | $99.77 | $104K |
| 99213 Office E&M - Established | Office | 827 | 376 | $69.00 | $57K |
By year: 2022 $2.4M for 199,125 services; 2023 $2.7M for 163,683 services; 2024 $3.8M for 260,606 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,302 | 747 | $7.58 | $17K |
| 36415 Venipuncture Blood Collection | 1,614 | 625 | $8.65 | $14K |
| 82728 Clinical Chemistry | 639 | 315 | $13.34 | $8,524 |
| 80048 Clinical Chemistry | 601 | 275 | $8.25 | $4,959 |
| 83540 Clinical Chemistry | 528 | 257 | $6.33 | $3,341 |
| 83550 Clinical Chemistry | 527 | 256 | $8.55 | $4,508 |
| 80053 Clinical Chemistry | 484 | 233 | $10.35 | $5,009 |
| 82607 Clinical Chemistry | 222 | 170 | $14.71 | $3,266 |
| 83615 Clinical Chemistry | 208 | 129 | $5.92 | $1,231 |
| 82746 Clinical Chemistry | 140 | 122 | $14.41 | $2,017 |
Medicare prescription drug claims, 2024
In 2024, the drug Phu N Tran prescribed most often to Medicare patients was Prednisone, with 129 prescriptions and refills. In total Phu N Tran wrote 2,752 Medicare prescriptions that cost $7.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 129 | 163 | 50 | $624 |
| Eliquis Apixaban | 128 | 146 | 30 | $84K |
| Oxycodone Hcl Generic | 106 | 106 | 60 | $1,430 |
| Anastrozole Generic | 91 | 202 | 26 | $1,161 |
| Hydroxyurea Generic | 90 | 186 | 23 | $2,727 |
| Ondansetron Hcl Generic | 87 | 87 | 57 | $818 |
| Lenalidomide Generic | 83 | 83 | 11 | $1.1M |
| Potassium Chloride Generic | 70 | 83 | 27 | $828 |
| Dexamethasone Generic | 70 | 76 | 31 | $1,341 |
| Xarelto Rivaroxaban | 56 | 94 | 14 | $52K |
| Acyclovir Generic | 54 | 78 | 16 | $674 |
| Doxycycline Hyclate Generic | 53 | 54 | 37 | $550 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 52 | 52 | Under 11 | $710K |
| Prochlorperazine Maleate Generic | 50 | 50 | 31 | $657 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 42 | 42 | 32 | $436 |
Brand drugs: - claims; generic drugs: 1,935 claims; opioid claims: 235.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Phu N Tran $15K ($15K in general payments such as food, travel and fees) from 39 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $8,269.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 18 | $8,269 |
| Karyopharm Therapeutics Inc. KPTI | 5 | $3,264 |
| Pfizer Inc. PFE | 35 | $504 |
| Novartis Pharmaceuticals Corporation NVS | 16 | $230 |
| Merck Sharp & Dohme LLC MRK | 9 | $211 |
| Janssen Biotech, Inc. JNJ | 16 | $202 |
| BeOne Medicines USA, Inc. ONC | 9 | $181 |
| GlaxoSmithKline, LLC. GSK | 12 | $179 |
| Genzyme Corporation SNY | 7 | $138 |
| Incyte Corporation INCY | 9 | $137 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.